Sickle Cell Disease (SCD): Clinical Trials

3 trials for Sickle Cell Disease (SCD), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 not yet recruiting, 1 recruiting. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Active not recruiting 1, Not yet recruiting 1, Recruiting 1
Phase 21Recruiting 1

Follow Sickle Cell Disease (SCD): new trials by email Literature Review of Sickle Cell Disease (SCD) trials Research Report on Sickle Cell Disease (SCD)

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Glutamine Early Start in Children With SCD Younger Than Five
Glutamine, Standard of Care (SOC) - Sickle Cell Disease (SCD)
Phase 3Not yet recruitingAin Shams University702026-12-012026-11-17
Optimizing Hydroxyurea Dosage With Pharmakokinetic in Patients Suffering of Moderate to Severe Sickle Cell Anemia
Pharmacokinetic based dosage change, Pharmacokinetic dosing - Sickle Cell Disease (SCD)
Phase 2 / Phase 3RecruitingYves Pastore292026-02-032026-08-21
Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients
Crizanlizumab (SEG101), Placebo - Sickle Cell Disease (SCD)
Phase 3Active not recruitingNovartis Pharmaceuticals2532019-07-262026-10-14

Narrower conditions

Anemia, Sickle Cell (3)  ·  Hematologic Diseases (1)  ·  Sickle Cell Trait (1)  ·  Vaso-Occlusive Crises (1)

Broader conditions

Anemia (3)  ·  Anemia, Hemolytic (3)  ·  Anemia, Hemolytic, Congenital (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Hemoglobinopathies (3)  ·  Hematologic Diseases (2)

Interventions

Glutamine (1)  ·  Standard of Care (1)  ·  crizanlizumab (1)

Sponsors

Ain Shams University (1)  ·  Novartis Pharmaceuticals (1)  ·  Yves Pastore (1)

Countries

Canada (2)  ·  Belgium (1)  ·  Brazil (1)  ·  Colombia (1)  ·  Egypt (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Ghana (1)  ·  Greece (1)  ·  India (1)  ·  Italy (1)  ·  Jordan (1)  ·  Lebanon (1)  ·  Netherlands (1)

Top investigators

Fatma SE Ebeid, MD (1)

Results publications

PMID 37254256, PMID 40088922

NIH funding

2017 (1)